Setastine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C22H28ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6G3OCF528J, chemically known as 1h-azepine, 1-(2-(1-(4-chlorophenyl)-1-phenylethoxy)ethyl)hexahydro- but generally known as setastine, which bears US NIH Compound Identifier 43082. European Medicines Agency schedules Setastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10500MIG. The term SETASTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, No. 3, 1988, List 28). SETASTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule setastine under HS 29339930 and SITC 51577. As of Q4 2014, SETASTINE remains the US FDA Preferred Term for this commodity. Setastine bears US NLM identifiers UMLS ID C0074409 and NCI Concept Code C73056. SMILES: CLC1CCC(C(OCCN2CCCCCC2)(C2CCCCC2)C)CC1.